2002
$120M
from 10 investors over 10 rounds
PhaseBio Pharmaceuticals, Inc. raised $120M on January 13, 2020
Investors: SFJ Pharmaceuticals, Inc.
PhaseBio Pharmaceuticals, Inc. raised $34M on September 5, 2018
Investors: Syno Capital, Fletcher Spaght, Inc. and Mountain Group Partners
PhaseBio Pharmaceuticals, Inc. raised $2.8M on February 27, 2018
Investors: National Institutes of Health
PhaseBio Pharmaceuticals, Inc. raised $40M on March 12, 2015
Investors: Fletcher Spaght, Inc.
PhaseBio Pharmaceuticals, Inc. raised $23M on June 5, 2012
Investors: Astellas Venture Capital L.L.C. and Fletcher Spaght, Inc.
PhaseBio Pharmaceuticals, Inc. raised $25M on January 7, 2010
Investors: Fletcher Spaght, Inc.
PhaseBio Pharmaceuticals, Inc. raised $6.6M on October 24, 2007
Investors: Fletcher Spaght, Inc.